Our insights
Brian Tora explores the effect of Afghanistan on markets, the planned Cobham takeover and the rising cost of living in his market commentary.
The threat of the Delta coronavirus variant could impact the global recovery.
James Godrich, fund manager of the JM Finn CSI funds, reviews some of the stocks in his funds.
The overwhelming view among senior scientists is that coronavirus is here to stay. Brian Tora provides his views on what we can expect in terms of a recovery in the next couple of months.
Freedom Day falls flat as UK stocks retreat. Brian Tora explores this and the uncertain economic outlook.
Head of research at JM Finn, Sir John Royden, is looking to become only the 8th person to swim the entire length of Lake Geneva unsupported.
The first six months of 2021 seems to have positively flown by and here we are in the second half of the year.
JM Finn picks up Best App/Portal of the Year at the annual Citywealth Brand Management & Reputation Awards
As lockdown eases Paul Tyndall, Investment Director at JM Finn discusses his view on returning to face-to-face meetings and why he values them so highly
What's the secret to investing for long-term value creation? Brian Tora discusses in our latest article
James Godrich, fund manager of the JM Finn CSI funds, reviews some of the stocks in his funds.
Macmillan Cancer receive over £3,500 from Simon Wong, after running 100k from London to Brighton
The summer doldrums may not be as much of a concern for investors this year with summer holidays abroad still seeming unlikely. Brian Tora provides his views on what we can expect from the next few…
ESG (Environment, Social and Governance), about which so much is written today, had a difficult birth. Back in the 1970s the doctrine was one of pure capitalism. Make as much money as possible…
If you like this article, follow us for more insights.
To receive more content like this subscribe today.